|Articles|June 19, 2017
Cognizant Announces Collaboration with TransCelerate BioPharma Inc.
Advertisement
Cognizant, in its collaboration with TransCelerate BioPharma Inc.-a non-profit organization containing members of global biopharmaceutical companies-announced its new Shared Investigator Platform (SIP) for clinical trial researchers. The platform is cloud-based and will help researchers access, share, and anayze data for the biopharmaceutical industry.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
2
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
3
FDA Approves Caplyta as Adjunctive Therapy for Major Depressive Disorder Based on Positive Phase III Results
4
ACT Brief: Designing Feasible Protocols and Breakthroughs in Obesity and Metabolic Research
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
